Gastric adenocarcinoma, the most common form of stomach cancer, develops in the mucus-producing cells lining the stomach and ranks among the world’s most deadly cancers, though its frequency varies dramatically across different regions.

Understanding Gastric Adenocarcinoma

Gastric adenocarcinoma is a type of cancer that begins in the glandular cells of the stomach—cells responsible for producing mucus and digestive juices. These cells exist in the mucosa, which is the innermost lining of the stomach. This particular form of stomach cancer accounts for approximately 90 to 95 percent of all stomach cancers diagnosed worldwide.^[1][2]

The stomach itself is a muscular organ located on the left side of the upper abdomen. It plays a crucial role in breaking down food that travels from the esophagus, mixing it with digestive juices and stomach acid before passing it along to the small intestine. When cancer cells form in this organ, they typically start small and grow slowly over many years, gradually penetrating deeper into the stomach walls and potentially spreading to other parts of the body.^[4]

Gastric adenocarcinoma can be classified based on where it forms within the stomach. In the United States, most cases develop in the area where the esophagus meets the stomach, called the gastric cardia. This type is known as gastric cardia cancer. In other parts of the world, particularly in countries where stomach cancer is more common, the disease more frequently develops in other sections of the stomach, referred to as non-cardia gastric cancer.^[4]

Epidemiology

Stomach cancer is the fifth most common cancer globally, with approximately 1.1 million new cases diagnosed each year and around 800,000 deaths annually. Despite being one of the leading causes of cancer-related death worldwide, its incidence varies dramatically by geographic region.^[13]

The highest rates of gastric cancer occur in Eastern Asia, particularly in countries like Japan and Mongolia, as well as in Eastern Europe. In contrast, Northern America and Northern Europe have much lower incidence rates, comparable to those found in African regions. This geographic variation suggests that environmental, dietary, and possibly genetic factors play significant roles in disease development.^[1][5]

In the United States, stomach cancer is relatively uncommon, representing only about 1.5 percent of all newly diagnosed cancers each year. Recent estimates suggest that approximately 26,000 to 30,000 people are diagnosed with stomach cancer annually in the U.S., with roughly 10,000 to 11,000 deaths.^[1][16]

Interestingly, stomach cancer rates in the United States have been declining steadily over the past several decades, particularly for cancers occurring in the main body of the stomach. This decline is believed to be linked to improved food storage methods, such as refrigeration, and changes in dietary patterns. However, rates of cancer at the gastroesophageal junction showed an increase from the 1970s through the 1980s before stabilizing in recent years.^[1][14]

Demographic patterns reveal that stomach cancer more commonly affects older individuals, with the average age at diagnosis being 68 years. Around 60 percent of cases occur in people over 65 years of age. Men are also at slightly higher risk than women for developing this disease.^[1]

Causes

Like all cancers, gastric adenocarcinoma develops when genetic mutations occur in the DNA of stomach cells. These mutations cause cells to grow rapidly and uncontrollably instead of following their normal life cycle of growth, division, and death. Over time, the accumulating abnormal cells form a tumor that can invade surrounding tissues and potentially spread to other parts of the body.^[3]

One of the most significant causes of gastric adenocarcinoma is infection with Helicobacter pylori (H. pylori), a type of bacteria that affects the stomach’s inner lining. Scientists estimate that H. pylori infections are responsible for between 46 and 63 percent of all stomach cancers. When this bacterial infection becomes chronic, it leads to long-term inflammation of the mucosa, which can eventually trigger the development of adenocarcinoma.^[3]

Another infectious cause, though less common, is the Epstein-Barr virus. This viral infection may cause between 5 and 10 percent of gastric adenocarcinomas. The virus can alter cell behavior in ways that promote cancer development.^[3]

In some cases, genetic mutations that increase cancer risk are inherited from biological parents. These inherited mutations can make individuals more susceptible to developing stomach cancer at younger ages or can be associated with specific genetic syndromes, such as Lynch syndrome, Peutz-Jeghers syndrome, or Li-Fraumeni syndrome. However, most gastric adenocarcinomas are not hereditary and develop due to mutations acquired over a person’s lifetime.^[3][17]

Risk Factors

Several factors can increase a person’s likelihood of developing gastric adenocarcinoma. Understanding these risk factors can help individuals make informed decisions about their health, though having one or more risk factors does not mean cancer will definitely develop.

Nutritional and dietary factors play a substantial role in stomach cancer risk. A diet high in salt, particularly from preserved, smoked, or cured foods, increases the chances of developing this cancer. Similarly, drinking contaminated water and consuming high amounts of nitrates and nitrites found in processed foods can elevate risk. On the other hand, diets low in fresh fruits and vegetables—which provide protective vitamins A and C—are associated with higher rates of stomach cancer. High caloric intake and obesity also contribute to increased risk.^[3]

Certain pre-existing medical conditions create an environment in the stomach that favors cancer development. Chronic atrophic gastritis, a condition where the stomach lining becomes inflamed and thins over time, significantly raises risk. Gastroesophageal reflux disease (GERD), where stomach acid frequently flows back into the esophagus, can also increase susceptibility. Other conditions include intestinal metaplasia, pernicious anemia, stomach polyps, and a rare condition called Ménétrier disease.^[1][17]

Lifestyle choices matter considerably. Smoking tobacco or using tobacco products like chewing tobacco is a recognized risk factor. Excessive alcohol consumption also increases the chances of developing stomach cancer. Previous stomach surgery can alter the stomach environment in ways that promote cancer years later.^[1][17]

Occupational exposures to certain substances raise risk as well. People who work with rubber, metal, coal, or who have been exposed to radiation face higher rates of gastric adenocarcinoma.^[3]

Family history cannot be overlooked. Having a first-degree relative—such as a parent or sibling—with stomach cancer increases an individual’s risk. This may be due to shared genetic factors, common environmental exposures, or similar lifestyle habits within families.^[15][17]

Symptoms

One of the greatest challenges with gastric adenocarcinoma is that it often does not cause noticeable symptoms during its early stages. This means many people are unaware they have cancer until it has progressed significantly. Even when symptoms do appear, they can be vague and easily mistaken for common digestive problems, which can delay diagnosis.^[3]

The most common early warning signs include unexplained weight loss and stomach pain or discomfort. The pain is often felt in the upper abdomen, typically above the belly button. Many people describe a persistent feeling of fullness or bloating even after eating only small amounts of food. This sensation, known as early satiety, occurs because the tumor may be physically blocking the stomach or affecting its ability to expand normally.^[3]

Digestive symptoms are frequent and troublesome. Loss of appetite is very common, and patients may simply not feel like eating. Heartburn and indigestion that don’t improve with over-the-counter medications can be warning signs. Nausea and vomiting may occur, and in more advanced cases, the vomit may contain blood. Similarly, blood may appear in the stool, making it look black and tarry, though sometimes the amount of blood is too small to see without medical testing.^[3]

As the disease progresses, additional symptoms can develop. Difficulty swallowing, particularly if the cancer is near the gastroesophageal junction, becomes more pronounced. Fatigue and weakness often set in, partly due to blood loss from the tumor and partly because of poor nutrition. If the cancer spreads to the liver, jaundice—a yellowing of the skin and eyes—may appear.^[3]

Prevention

While it is not always possible to prevent gastric adenocarcinoma, several lifestyle modifications and medical interventions can reduce risk. These preventive strategies address the modifiable risk factors associated with this disease.

Dietary changes form the cornerstone of prevention. Reducing consumption of salted, smoked, pickled, and preserved foods can lower exposure to harmful compounds that promote cancer development. Instead, eating a diet rich in fresh fruits and vegetables provides protective antioxidants and vitamins, particularly vitamins A and C, which help maintain healthy stomach tissue. Limiting processed meats and foods high in nitrates and nitrites is also beneficial.^[1]

Treating H. pylori infections when they are detected can significantly reduce stomach cancer risk. If diagnosed with this bacterial infection, completing the full course of antibiotic therapy prescribed by a healthcare provider is essential. In regions where stomach cancer is common, some public health programs even screen for H. pylori as a preventive measure.^[3]

Lifestyle modifications related to tobacco and alcohol use are important. Quitting smoking or never starting reduces risk considerably. Similarly, limiting alcohol consumption or abstaining altogether helps protect the stomach lining from damage. Maintaining a healthy weight through balanced eating and regular physical activity also contributes to lower cancer risk.^[1]

For individuals with chronic conditions that increase stomach cancer risk, such as GERD or chronic gastritis, proper management of these conditions is crucial. This may involve medications, dietary adjustments, or regular monitoring by healthcare professionals to detect any early changes in the stomach lining.

Regular screening is another preventive approach, though it is not standard practice in countries with low stomach cancer rates like the United States. However, in nations with high incidence rates, such as Japan and South Korea, mass screening programs using upper endoscopy have been effective in detecting cancers at earlier, more treatable stages. People with a strong family history of stomach cancer or genetic syndromes associated with increased risk may benefit from personalized screening recommendations.^[16]

Pathophysiology

Understanding how gastric adenocarcinoma develops at a cellular level helps explain why the disease behaves the way it does. The pathophysiology describes the abnormal changes that occur in the stomach from the earliest cellular mutations through tumor formation and potential spread.

The disease typically begins with small genetic changes in the DNA of cells within the stomach’s mucosa. These mutations interfere with the normal cell cycle, causing cells to divide more rapidly than they should and preventing them from dying when they normally would. As these abnormal cells accumulate, they form clusters that gradually develop into tumors. The cancer cells look different from normal cells when examined under a microscope—they may appear poorly organized and lack the specialized features of healthy stomach cells.^[3]

Gastric adenocarcinomas are often classified by how differentiated the cancer cells appear. Well-differentiated tumors, where cancer cells still resemble normal stomach cells, tend to grow more slowly and have better prognoses. Poorly differentiated or undifferentiated tumors, where cells look very abnormal and nothing like healthy cells, generally grow and spread more aggressively. This classification helps doctors predict how the cancer might behave and guides treatment decisions.^[7]

As the tumor grows, it initially remains confined to the mucosa. However, gastric adenocarcinoma doesn’t stay in one place. It progressively invades deeper layers of the stomach wall, moving from the mucosa through the muscular layers and eventually reaching the outer surface of the stomach. This penetration through stomach layers is how staging is determined, with deeper invasion indicating more advanced disease.^[4]

The cancer can spread in several ways. Local spread occurs when the tumor grows directly into nearby organs such as the pancreas, liver, or intestines. Lymphatic spread happens when cancer cells break away from the primary tumor and travel through lymph vessels to nearby lymph nodes. Regional lymph nodes are often the first sites where the cancer spreads. From there, cancer cells can reach more distant lymph nodes throughout the body.^[1]

In more advanced cases, cancer cells can enter the bloodstream and spread to distant organs—a process called metastasis. The liver and lungs are common sites for metastatic gastric cancer, though it can also spread to bones, brain, and other organs. Once the cancer has metastasized, treatment becomes more challenging and the prognosis generally worsens.^[6]

Chronic inflammation plays a crucial role in the development of gastric adenocarcinoma. When H. pylori infection persists for years, the constant inflammatory response damages stomach cells and creates an environment conducive to genetic mutations. This chronic inflammation can progress through several stages: from normal mucosa to chronic gastritis, then to intestinal metaplasia (where stomach cells are replaced by intestine-like cells), and eventually to dysplasia (pre-cancerous changes) before frank cancer develops. This progression can take many years or even decades, which is why gastric adenocarcinoma is more common in older adults.^[3]

Certain molecular characteristics of the tumor also influence its behavior. For example, tumors that overexpress HER2 (human epidermal growth factor receptor 2), a protein that promotes cell growth, may grow more aggressively but can be targeted with specific therapies. Similarly, tumors with microsatellite instability (MSI), a condition where DNA repair mechanisms are faulty, often respond better to certain types of immunotherapy. Understanding these molecular features has become increasingly important for personalizing treatment approaches.^[9][13]